FDA Approves First Human Trial for Potential CRISPR-Led HIV Cure

Share This Story, Choose Your Platform!

The first-in-human clinical trial for a candidate treatment for individuals living with human immunodeficiency virus type 1 is starting soon after its maker, Excision BioTherapeutics, today received an Investigational New Drug clearance from the U.S. Food and Drug Administration (FDA). Read more…